Proxim Diagnostics

Proxim Diagnostics was founded with the core mission of revolutionizing point-of-care testing by delivering precise laboratory results instantly to healthcare providers. Their vision is to enhance patient care by providing critical diagnostic information at the moment it is needed most. Proxim's flagship product is a next-generation handheld immunodiagnostic device capable of performing essential laboratory tests using whole blood, ensuring high sensitivity and precision. The company primarily focuses on markets requiring rapid and accurate diagnostic solutions, such as emergency medicine and infectious disease control.

Notable figures affiliated with Proxim Diagnostics include leading experts in medical diagnostics and technology innovation. The company has attracted significant investment from prominent venture capital firms specializing in healthcare technology. Key achievements include the development and deployment of their COVID-19 Antigen Test and COVID-19 Risk Assessment tools, which have had a substantial impact during the pandemic. Overall, Proxim Diagnostics has significantly advanced the field of point-of-care testing, improving patient outcomes through timely and accurate diagnostics.